SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-024215
Filing Date
2024-06-18
Accepted
2024-06-18 08:00:17
Documents
14
Period of Report
2024-06-17
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40115
  Complete submission text file 0001493152-24-024215.txt   257971

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cing-20240617.xsd EX-101.SCH 3781
3 XBRL DEFINITION FILE cing-20240617_def.xml EX-101.DEF 26635
4 XBRL LABEL FILE cing-20240617_lab.xml EX-101.LAB 36718
5 XBRL PRESENTATION FILE cing-20240617_pre.xml EX-101.PRE 25259
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5714
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40874 | Film No.: 241050210
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)